Federal contract award
75N93021P01337
PLATINUM TAQ HIGH FIDELITY, 5000 & PLATINUM SUPERFI II DNA POLYMERASE, 2500 KITS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6509 — Drugs and Biologicals, Veterinary Use. |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | $0 |
| Potential contract value / ceiling | $0 |
| Start date | Sep 7, 2021 |
| Current end date | Feb 28, 2022 |
| Potential end date | Feb 28, 2022 |
| Latest award activity | Aug 26, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 26, 2026 | P00002 | $-44.1K | TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Feb 18, 2022 | P00001 | $0 | PLATINUM TAQ HIGH FIDELITY, 5000 & PLATINUM SUPERFI II DNA POLYMERASE, 2500 KITS |
| Sep 7, 2021 | 0 | $44.1K | PLATINUM TAQ HIGH FIDELITY, 5000 & PLATINUM SUPERFI II DNA POLYMERASE, 2500 KITS |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Jesse Weidow | Contact | jesse.weidow@nih.gov | Source | Aug 27, 2021 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.